Log in to save to my catalogue

A self-adjuvanted VLPs-based Covid-19 vaccine proven versatile, safe, and highly protective

A self-adjuvanted VLPs-based Covid-19 vaccine proven versatile, safe, and highly protective

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2d12047389a5455f9bfa8269f9ac2ba4

A self-adjuvanted VLPs-based Covid-19 vaccine proven versatile, safe, and highly protective

About this item

Full title

A self-adjuvanted VLPs-based Covid-19 vaccine proven versatile, safe, and highly protective

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2024-10, Vol.14 (1), p.24228-17, Article 24228

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Vaccination has played a critical role in mitigating COVID-19. Despite the availability of licensed vaccines, there remains a pressing need for improved vaccine platforms that provide high protection, safety, and versatility, while also reducing vaccine costs. In response to these challenges, our aim is to create a self-adjuvanted vaccine against S...

Alternative Titles

Full title

A self-adjuvanted VLPs-based Covid-19 vaccine proven versatile, safe, and highly protective

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_2d12047389a5455f9bfa8269f9ac2ba4

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2d12047389a5455f9bfa8269f9ac2ba4

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-024-76163-w

How to access this item